Home/Filings/4/0001104659-20-027330
4//SEC Filing

Weyer Christian 4

Accession 0001104659-20-027330

CIK 0001270073other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 7:00 PM ET

Size

6.5 KB

Accession

0001104659-20-027330

Insider Transaction Report

Form 4
Period: 2020-02-27
Weyer Christian
EVP Research and Development
Transactions
  • Tax Payment

    Common Stock

    2020-02-27$85.39/sh357$30,48417,480 total
  • Sale

    Common Stock

    2020-02-27$87.62/sh113$9,90117,367 total
Footnotes (2)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.
  • [F2]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1
  • filerCIK 0001493811

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:00 PM ET
Size
6.5 KB